|
|
|
Company
Name |
Short
Summary |
| Ascenta Therapeutics |
Ascenta Therapeutics is focused on research and development of orally administered small molecule drugs that restore the natural potential for cancer cells to undergo apoptosis. |
| AltheRx Pharmaceuticals |
AltheRx Pharmaceuticals is focused on the develoment of the development of Solabegron, a β-Adrenoceptor agonist, for a variety of indications. |
| Auxilium Pharmaceuticals |
Auxilium Pharmaceuticals is focused on the develolpment and commercialization of products in various therapeutic areas. |
| Ceptaris Therapeutics |
Ceptaris Therapeutics is focused on the development of a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides. |
| Charles
River Laboratories |
Charles River Laboratories is a global provider of solutions that advance the drug discovery and development process. Charles River Laboratories is the
largest laboratory animal production company in
the world, and also offers a number of preclinical and clinical support capabilities. |
| Endo
Pharmaceuticals |
Endo
Pharmaceuticals is involved in the research, development,
comercialization and marketing of prescription pharmaceuticals
to treat and manage pain. |
| PhaseBio |
PhaseBio is focused on the research and development of treatments for patinets with endocrine, metabolic and cardiovascular disease. |
| Progenra |
Progenra is focused on the discovery and development of drugs for a variety of diseases through targeting of the ubiquitin pathway. |
| Sanofi-Aventis |
Sanofi-Aventis is a large pharmaceutical company focused on the discovery, development, and commercialization of a wide range of drugs. A research and development facility is located in Malvern. |
| TetraLogic Pharmaceuticals |
TetraLogic Pharmaceuticals is focused on the discovery and development of small molecule drugs that modulate apoptosis to treat disease. |
